Detalhe da pesquisa
1.
Hematological, clinical, immunophenotypic characterization, and treatment outcomes of prognostically significant genetic subtypes of B-lineage acute lymphoblastic leukemia: A report of 1021 patients from India.
Cancer
; 129(21): 3390-3404, 2023 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37498973
2.
A Genome-Wide CRISPR Activation Screen Identifies PRRX2 as a Regulator of Enzalutamide Resistance in Prostate Cancer.
Cancer Res
; 82(11): 2110-2123, 2022 06 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35405009
3.
A MYC inhibitor selectively alters the MYC and MAX cistromes and modulates the epigenomic landscape to regulate target gene expression.
Sci Adv
; 8(17): eabh3635, 2022 04 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35476451
4.
Turning Up the Heat on MYC: Progress in Small-Molecule Inhibitors.
Cancer Res
; 81(2): 248-253, 2021 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33087323
5.
FIREWORKS: a bottom-up approach to integrative coessentiality network analysis.
Life Sci Alliance
; 4(2)2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33328249
6.
Small-Molecule MYC Inhibitors Suppress Tumor Growth and Enhance Immunotherapy.
Cancer Cell
; 36(5): 483-497.e15, 2019 11 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31679823
7.
Dinuclear zinc-ProPhenol-catalyzed enantioselective α-hydroxyacetate aldol reaction with activated ester equivalents.
Org Lett
; 15(17): 4516-9, 2013 Sep 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-23947595